Bivalirudin versus Heparin in Primary Percutaneous Coronary Intervention- a Meta analysis

被引:0
作者
Narayanan, Mahesh Anantha [1 ]
Reddy, Yogesh N. V. [2 ]
Anugula, Dixitha [3 ]
Gujjula, Nagarjuna [3 ]
Badheka, Apurva [4 ]
Deshmukh, Abhishek [2 ]
Kaushik, Manu [5 ]
Raveendran, Ganesh [6 ]
机构
[1] Univ Minnesota, Roseville, MN USA
[2] Mayo Clin, Rochester, MN USA
[3] Creighton Univ, Med Ctr, CHI Hlth, Omaha, NE USA
[4] Everett Clin, Everett, WA USA
[5] NWI VA Med Ctr, Omaha, NE USA
[6] Univ Minnesota, St Paul, MN 55108 USA
关键词
D O I
10.1016/j.jacc.2016.09.298
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
TCT-156
引用
收藏
页码:B64 / B64
页数:1
相关论文
共 50 条
[21]   Meta-Analysis of Effects of Bivalirudin Versus Heparin on Myocardial Ischemic and Bleeding Outcomes After Percutaneous Coronary Intervention [J].
Perez, Alberto E. Barria ;
Rao, Sunil V. ;
Jolly, Sanjit J. ;
Pancholy, Samir B. ;
Plourde, Guillaume ;
Rimac, Goran ;
Poirier, Yann ;
Costerousse, Olivier ;
Bertrand, Olivier F. .
AMERICAN JOURNAL OF CARDIOLOGY, 2016, 117 (08) :1256-1266
[22]   BIVALIRUDIN VERSUS HEPARIN IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION IN ACUTE CORONARY SYNDROMES [J].
Qadeer, Yusuf K. ;
Krittanawong, Chayakrit ;
Wang, Zhen ;
Ahuja, Tania ;
Alam, Mahboob ;
Jneid, Hani .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2025, 85 (12) :949-949
[23]   Benefit of Bivalirudin Versus Heparin After Transradial and Transfemoral Percutaneous Coronary Intervention [J].
MacHaalany, Jimmy ;
Abdelaal, Eltigani ;
Bataille, Yoann ;
Plourde, Guillaume ;
Duranleau-Gagnon, Pierre ;
Larose, Eric ;
Dery, Jean-Pierre ;
Barbeau, Gerald ;
Rinfret, Stephane ;
Rodes-Cabau, Josep ;
De Larochelliere, Robert ;
Roy, Louis ;
Costerousse, Olivier ;
Bertrand, Olivier F. .
AMERICAN JOURNAL OF CARDIOLOGY, 2012, 110 (12) :1742-1748
[24]   Comparison of patient outcomes with bivalirudin versus unfractionated heparin in percutaneous coronary intervention [J].
Watson, Kristin ;
Seybert, Amy L. ;
Saul, Melissa I. ;
Lee, Joon Sup ;
Kane-Gill, Sandra L. .
PHARMACOTHERAPY, 2007, 27 (05) :647-656
[25]   Heparin versus bivalirudin for percutaneous coronary intervention: has the debate come to an end? [J].
Elgendy, Islam Y. ;
Capodanno, Davide .
JOURNAL OF THORACIC DISEASE, 2017, 9 (11) :4305-4307
[26]   Platelet Activity in Primary Percutaneous Coronary Intervention Patients Randomized to Bivalirudin or Heparin [J].
Venetsanos, Dimitrios ;
Swahn, Eva ;
Lawesson, Sofia Sederholm ;
Gustafsson, Kerstin M. ;
Erlinge, David ;
Lindahl, Tomas L. ;
Alfredsson, Joakim .
CIRCULATION, 2017, 136
[27]   Efficacy and safety of bivalirudin versus heparin in patients undergoing percutaneous coronary intervention: A meta-analysis of randomized controlled trials [J].
Zhang, Shuo ;
Gao, Weihua ;
Li, Haixia ;
Zou, Meijuan ;
Sun, Sihao ;
Ba, Yijie ;
Liu, Yang ;
Cheng, Gang .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 209 :87-95
[28]   A meta-analysis and cost-minimization analysis of bivalirudin versus heparin in high-risk patients for percutaneous coronary intervention [J].
Sun, Ke-Xin ;
Cui, Bin ;
Cao, Shan-Shan ;
Wang, Wen-Jun ;
Yu, Feng ;
Wang, Jing-Wen ;
Ding, Yi .
PHARMACOLOGY RESEARCH & PERSPECTIVES, 2021, 9 (03)
[29]   Heparin Versus Bivalirudin in Acute Myocardial Infarction: Unfractionated Heparin Monotherapy Elevated to Primary Treatment in Contemporary Percutaneous Coronary Intervention [J].
Centurion, Osmar Antonio .
OPEN CARDIOVASCULAR MEDICINE JOURNAL, 2016, 10 :122-129
[30]   BIVALIRUDIN VERSUS UNFRACTIONED HEPARIN IN PATIENTS RECEIVING PERCUTANEOUS CORONARY INTERVENTION FOR ACUTE CORONARY SYNDROMES [J].
Farag, Mohamed ;
Gorog, Diana ;
Srinivasan, Manivannan .
HEART, 2015, 101 :A9-A9